---
title: "\"Innoscience\" mid-term loss narrowed to 429 million yuan, gross profit turned positive"
description: "INNOSCIENCE announced its interim results, with sales revenue reaching 553 million RMB, a year-on-year increase of 43.4%. The loss narrowed from 488 million RMB in the same period last year to 429 mil"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/255047937.md"
published_at: "2025-08-28T14:56:30.000Z"
---

# "Innoscience" mid-term loss narrowed to 429 million yuan, gross profit turned positive

> INNOSCIENCE announced its interim results, with sales revenue reaching 553 million RMB, a year-on-year increase of 43.4%. The loss narrowed from 488 million RMB in the same period last year to 429 million RMB, with a loss per share of 0.49 RMB. The gross margin improved from -21.6% to 6.8%, achieving a gross profit of 37.85 million RMB. The company has engaged in strategic cooperation with several traditional power chip manufacturers and AI data center companies in Europe and the United States, promoting the application of gallium nitride chips in various fields. Overseas business revenue grew by 57.8%, accounting for 11.5% of total revenue

INNOSCIENCE (02577.HK) announced its interim results for the six months ending in June, with sales revenue of 553 million RMB, an increase of 43.4% year-on-year, mainly due to the continuous expansion of the gallium nitride application field and rapid growth in customer demand. The loss narrowed from 488 million RMB in the same period last year to 429 million RMB, with a loss per share of 0.49 RMB. No dividend was declared.

In the first half of the year, the gross profit margin was 6.8%, compared to -21.6% in the same period last year, an improvement of 284 basis points, mainly benefiting from increased revenue, the release of production scale effects, and continuous optimization of production processes to reduce costs; achieving a positive gross profit of 37.85 million RMB.

The company has engaged in strategic cooperation with several traditional power chip manufacturers in Europe and the United States, as well as leading AI data center companies, to promote the large-scale application of gallium nitride chip solutions in consumer electronics, automotive electronics, and AI data centers. During the period, overseas business revenue was 63.7 million RMB, an increase of 57.8%, accounting for 11.5% of total revenue

### Related Stocks

- [02577.HK - INNOSCIENCE](https://longbridge.com/en/quote/02577.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 早盤趨勢｜英諾賽科逼近支撐，資金博弈或迎短線節點？ | 英諾賽科（2577.HK）目前股價持續走低，逼近前期關鍵支撐區域。日線 MACD 已形成死叉，技術形態短線偏空，説明主力資金處於防禦性姿態。成交量持續低迷，部分資金嘗試低吸博弈支撐，但參與意願有限，整體跟風盤觀望情緒濃郁。 行業基本面方面， | [Link](https://longbridge.com/en/news/271623973.md) |
| 早盤趨勢｜英諾賽科量能放大，弱勢下新動作要來了？ | 英諾賽科（2577.HK）近期交易日內成交量明顯放大，儘管整體股價依然位於回調下行通道，主力在弱勢態勢下的資金異動意味濃厚。技術層面來看，股價此前多日於低位區間築底後於昨日出現較為顯著的量能釋放，日線 K 線組合上插針下影，反映市場博弈激烈 | [Link](https://longbridge.com/en/news/271483660.md) |
| 索羅斯逆市加碼微軟及 Nvidia 等科企 新買入黃金股 清倉 4 隻股份 | 索羅斯基金管理公司在 2022 年第四季度加大對微軟、英偉達和蘋果等大型科技股的投資，同時增持黃金股以對衝風險。基金還增持了 Atlassian、Salesforce 和 Uber 等軟體公司股票，但大幅減持了 Snowflake 和 Ci | [Link](https://longbridge.com/en/news/275990619.md) |
| 東和製藥（TSE:4553）在 2026 年第三季度利潤率的堅挺強化了其防禦性收益的説法 | 東和藥品（TSE:4553）公佈了 2026 年第三季度的穩健業績，收入為 736 億日元，淨利潤為 89 億日元，反映出同比增長 11.2% 的盈利增長和 7.9% 的淨利潤率。儘管這些數據積極，但未來的盈利預計年增長率僅為 0.89%， | [Link](https://longbridge.com/en/news/275991027.md) |
| 埃隆·馬斯克表示，特斯拉將在他所能想象的未來時間內，擁有 “最大規模” 的自動駕駛車隊 | 埃隆·馬斯克，特斯拉公司（NASDAQ:TSLA）首席執行官，宣佈他設想特斯拉未來將擁有最大的自動駕駛汽車車隊，這與公司的長期目標和人工智能投資相一致。特斯拉目前正在奧斯汀測試其機器人出租車，並與 Waymo 等公司競爭。自動駕駛汽車的競爭 | [Link](https://longbridge.com/en/news/276007509.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.